ACT001, a novel PAI-1 inhibitor, exerts synergistic effects in combination with cisplatin by inhibiting PI3K/AKT pathway in glioma

Oncogenic role of arsenic exposure in lung cancer: A forgotten risk factor

(2019) Cristian Soza-Ried et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Plasminogen activator inhibitor-1 in cancer research

(2018) Sijing Li et al.   BIOMEDICINE & PHARMACOTHERAPY

PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells

(2018) Hehui Fang et al.   CANCER SCIENCE

Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia

(2018) Jing Li et al.   JOURNAL OF MEDICINAL CHEMISTRY

MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133+ Glioblastoma Stem Cells

(2018) Liang Yang et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin

(2017) M. Luo et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients

(2017) Yu Wang et al.   MEDICINE

Label-free quantification in ion mobility–enhanced data-independent acquisition proteomics

(2016) Ute Distler et al.   Nature Protocols

Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing

(2015) V. R. Placencio et al.   CANCER RESEARCH

Targeting the PI3K/AKT/mTOR Signaling Pathway in Medulloblastoma

(2015) V. Dimitrova et al.   CURRENT MOLECULAR MEDICINE

Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine

(2015) Feng-Ying Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

PI3K and AKT: Unfaithful Partners in Cancer

(2015) Seraina Faes et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma

(2015) LIANG CHANG et al.   Molecular Medicine Reports

Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients

(2015) Miguel Angel Pavón et al.   Oncotarget

Micheliolide Derivative DMAMCL Inhibits Glioma Cell Growth In Vitro and In Vivo

(2015) Yinghong An et al.   PLoS One

Epidemiologic and Molecular Prognostic Review of Glioblastoma

(2014) J. P. Thakkar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The cellular thermal shift assay for evaluating drug target interactions in cells

(2014) Rozbeh Jafari et al.   Nature Protocols

Tracking cancer drugs in living cells by thermal profiling of the proteome

(2014) M. M. Savitski et al.   SCIENCE

Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay

(2013) D. M. Molina et al.   SCIENCE

Guaianolide Sesquiterpene Lactones, a Source To Discover Agents That Selectively Inhibit Acute Myelogenous Leukemia Stem and Progenitor Cells

(2012) Quan Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Prognostic impact of plasminogen activator inhibitor type 1 expression in bladder cancer

(2010) Markus Becker et al.   CANCER

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients

(2008) G. Minniti et al.   JOURNAL OF NEURO-ONCOLOGY